JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M603106200 on August 31, 2006

J. Biol. Chem., Vol. 281, Issue 43, 32240-32253, October 27, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/43/32240    most recent
M603106200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiltunen, M.
Right arrow Articles by Tanzi, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiltunen, M.
Right arrow Articles by Tanzi, R. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and Abeta Secretion*

Mikko Hiltunen{ddagger}1, Alice Lu{ddagger}1, Anne V. Thomas§, Donna M. Romano{ddagger}, Minji Kim{ddagger}, Phill B. Jones, Zhongcong Xie{ddagger}, Maria Z. Kounnas||, Steven L. Wagner||, Oksana Berezovska§, Bradley T. Hyman§, Giuseppina Tesco{ddagger}, Lars Bertram{ddagger}, and Rudolph E. Tanzi{ddagger}2

From the {ddagger}Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts 02129, the §Alzheimer's Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts 02129, the Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, and ||Torrey Pines Therapeutics, Inc., La Jolla, California 92037

Ubiquilin 1 (UBQLN1) is a ubiquitin-like protein, which has been shown to play a central role in regulating the proteasomal degradation of various proteins, including the presenilins. We recently reported that DNA variants in UBQLN1 increase the risk for Alzheimer disease, by influencing expression of this gene in brain. Here we present the first assessment of the effects of UBQLN1 on the metabolism of the amyloid precursor protein (APP). For this purpose, we employed RNA interference to down-regulate UBQLN1 in a variety of neuronal and non-neuronal cell lines. We demonstrate that down-regulation of UBQLN1 accelerates the maturation and intracellular trafficking of APP, while not interfering with {alpha}-, beta-, or {gamma}-secretase levels or activity. UBQLN1 knockdown increased the ratio of APP mature/immature, increased levels of full-length APP on the cell surface, and enhanced the secretion of sAPP ({alpha}- and beta-forms). Moreover, UBQLN1 knockdown increased levels of secreted Abeta40 and Abeta42. Finally, employing a fluorescence resonance energy transfer-based assay, we show that UBQLN1 and APP come into close proximity in intact cells, independently of the presence of the presenilins. Collectively, our findings suggest that UBQLN1 may normally serve as a cytoplasmic "gatekeeper" that may control APP trafficking from intracellular compartments to the cell surface. These findings suggest that changes in UBQLN1 steady-state levels affect APP trafficking and processing, thereby influencing the generation of Abeta.


Received for publication, March 31, 2006 , and in revised form, August 8, 2006.

* This work was supported by the Extendicare Foundation and the Finnish Academy (to M. H.), National Institutes of Health (NIH) Grant 5 P01 AG015379-08 (to B. T. H.), NIA, NIH Grant 1R01 AG023667-01 (to L. B.), Mass Alzheimer's Disease Research Center pilot Grant 218683 (to O. B.), and a research fellowship from the Deutsche Forschungsgemeinschaft (Grant TH 1129/1-1 to A. V. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 To whom correspondence should be addressed: Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, and Harvard Medical School, 114 16th St. C3009, Charlestown, MA 02129-4404. Tel.: 617-726-6845; Fax: 617-724-1949; E-mail: tanzi{at}helix.mgh.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
W. S. Liang, T. Dunckley, T. G. Beach, A. Grover, D. Mastroeni, K. Ramsey, R. J. Caselli, W. A. Kukull, D. McKeel, J. C. Morris, et al.
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set
Physiol Genomics, April 21, 2008; 33(2): 240 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-S. Hoe, S. S. Minami, A. Makarova, J. Lee, B. T. Hyman, Y. Matsuoka, and G. W. Rebeck
Fyn Modulation of Dab1 Effects on Amyloid Precursor Protein and ApoE Receptor 2 Processing
J. Biol. Chem., March 7, 2008; 283(10): 6288 - 6299.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Ganguly, R.M. R. Feldman, and M. Guo
ubiquilin antagonizes presenilin and promotes neurodegeneration in Drosophila
Hum. Mol. Genet., January 15, 2008; 17(2): 293 - 302.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Li, Z. Xie, Y. Dong, K. M. McKay, M. L. McKee, and R. E. Tanzi
Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: in vivo interaction with early-onset Alzheimer disease genes
Hum. Mol. Genet., November 1, 2007; 16(21): 2626 - 2639.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. J. Huttunen, S. Y. Guenette, C. Peach, C. Greco, W. Xia, D. Y. Kim, C. Barren, R. E. Tanzi, and D. M. Kovacs
HtrA2 Regulates beta-Amyloid Precursor Protein (APP) Metabolism through Endoplasmic Reticulum-associated Degradation
J. Biol. Chem., September 21, 2007; 282(38): 28285 - 28295.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Chen, X. Wang, J. Yu, S. Varambally, J. Yu, D. G. Thomas, M.-Y. Lin, P. Vishnu, Z. Wang, R. Wang, et al.
Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma
Cancer Res., April 1, 2007; 67(7): 3461 - 3467.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.